Impact of Eliminating Cost-Sharing by Medicare Beneficiaries for Follow-Up Colonoscopy After a Positive Stool-Based Colorectal Cancer Screening Test.
Ontology highlight
ABSTRACT: Medicare coverage of a follow-up colonoscopy after a positive stool-based colorectal cancer (CRC) screening test with no patient cost-sharing started January 2, 2023, which may favorably affect screening behavior. This analysis estimated the clinical and economic effects of increased CRC screening participation potentially resulting from this policy change in Medicare beneficiaries. The validated CRC-AIM model simulated three guideline-endorsed CRC screening strategies for average-risk individuals (colonoscopy every 10 years, annual fecal immunochemical test, triennial multi-target stool DNA) from ages 65-75 years. The base-case scenario assumed 0% coinsurance for initial screening and follow-up colonoscopy, real-world screening test use (colonoscopy=45.3%, stool-based test=24.4%, unscreen
SUBMITTER: Fendrick AM
PROVIDER: S-EPMC10581033 | biostudies-literature | 2023 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA